A prognostic index built from a trio of genes, inclusive of CPXM1, correlated with responsiveness to immune checkpoint inhibitors (ICI) in head and neck squamous cell carcinoma [41]. Here, CPXM1 is linked to head and neck squamous cell carcinoma.